Imagion Biosystems has announced “Notice of Annual General Meeting/Proxy Form.”
Click here to view the notice (726 KB pdf)
Corporate Update – IND for MagSense® HER2 Phase 2 Study Immediate Priority
Corporate Updates: $3M fundraising led by CPS Capital to be completed in early December Filing of IND for MagSense® HER2 Phase 2 Study Immediate Priority